Macrophage polarization state

Macrophage polarization state refers to the functional plasticity of macrophages, which can transition between pro-inflammatory (M1) and anti-inflammatory/pro-resolving (M2) phenotypes based on microenvironmental signals (PubMed: 24445666). This polarization is governed by complex signaling networks, including the JAK/STAT and NF-κB pathways, and is essential for effective immune responses and tissue homeostasis (PubMed: 21239723). In oncology, the prevalence of M2-polarized tumor-associated macrophages (TAMs) is often associated with poor prognosis due to their role in promoting angiogenesis and suppressing T-cell activity (PubMed: 24631447). Conversely, excessive M1 polarization can lead to chronic inflammatory conditions and tissue damage (PubMed: 28438233). Therapeutic strategies currently under investigation aim to reprogram these states, such as using CSF1R inhibitors or TLR agonists to shift TAMs from an M2 to an M1 phenotype to enhance anti-tumor immunity (PubMed: 30546054). As a phenotypic state rather than a single protein, it represents a high-level therapeutic objective achieved by modulating specific molecular targets within the macrophage signaling architecture.

Other names

Macrophage polarizationM1/M2 polarizationMacrophage activation state

Drugs modulate macrophage polarization by targeting specific signaling pathways (e.g., JAK/STAT, TLR, CSF1R) or metabolic checkpoints to shift the phenotype from a pro-inflammatory (M1) to an anti-inflammatory (M2) state, or vice versa, depending on the therapeutic goal (PubMed: 30546054).